medication past present and future in racing and performance horses l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Medication: Past, Present, and Future in Racing and Performance Horses PowerPoint Presentation
Download Presentation
Medication: Past, Present, and Future in Racing and Performance Horses

Loading in 2 Seconds...

play fullscreen
1 / 14

Medication: Past, Present, and Future in Racing and Performance Horses - PowerPoint PPT Presentation


  • 666 Views
  • Uploaded on

Medication: Past, Present, and Future in Racing and Performance Horses. Scot Waterman, DVM Executive Director. Racing Medication & Testing Consortium. Began in 2001 at a facilitated meeting hosted by the AAEP to assess whether uniform medication rules were achievable

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Medication: Past, Present, and Future in Racing and Performance Horses' - daniel_millan


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
medication past present and future in racing and performance horses

Medication: Past, Present, and Future in Racing and Performance Horses

Scot Waterman, DVM

Executive Director

racing medication testing consortium
Racing Medication & Testing Consortium
  • Began in 2001 at a facilitated meeting hosted by the AAEP to assess whether uniform medication rules were achievable
  • RMTC Goals: uniform rules, standardized testing, available money for research, improved security, information resource for racing commissions
  • Incorporated as a 501 c (3)
board of directors
AAEP

AQHA

Arabian Jockey Club

California TB Trainers

Churchill Downs

Del Mar

Hambletonian Society

Harness Tracks of America

The Jockey Club     

Jockeys’ Guild

Keeneland

KTA

Magna Entertainment

National HBPA

NTRA

NYRA

Oak Tree

RCI

THA

TOBA

TB Owners of California

TRA

TRPB

USTA

Board of Directors
racing medication testing consortium4
Racing Medication & Testing Consortium
  • Diverse, large Board can be difficult but it ensures that no single agenda can drive the development of a rule, supermajority required for language to pass
  • Standard approach is to divide work up into sub-committees and bring the consensus back to the full Board
  • Language is either adopted by the Board, edited and then approved or sent back to the sub-committee
veterinarian involvement in the rmtc
Board members

Rick Arthur

(Oak Tree)

Nancy Goodman (AQHA)

Ted Hill

(The Jockey Club)

Bobby Lewis

(AAEP)

Gregg Scoggins

(MEC)

Ex officio

Glenn Blodgett (AQHA)

Ron Jensen (Advisor)

Milton McLure (AAEP)

Wayne McIlwraith (AAEP)

Committees

Tom Brokken

Gary Norwood

Dan Wilson

Tom Tobin

Mike Weber

Veterinarian involvement in the RMTC
model rules phase 1 2005
Model Rules Phase 1 (2005)
  • Prohibited Practices
  • Drug Classifications/Categorization
  • Permitted Therapeutics:
    • Voluntary use of furosemide with post-race regulatory control
    • One of three NSAIDs – Bute, Banamine or Ketoprofen – at 24 hours
  • Adopted now by 32/38 racing jurisdictions
uniform penalties 2006
Uniform Penalties (2006)
  • Three-tiered grid system simplified existing RCI penalties
  • Significantly increases penalties for illegal and prohibited performance-enhancing drugs
  • Reduces penalties for therapeutic medication mistakes
  • Redefines trainer responsibility
    • Mitigating and aggravating circumstances “checklist” for stewards
    • Added penalties for other culpable licensees: veterinarians, owners and grooms
  • Adopted as rule or policy in 25 states
model rules phase 3 2007
Model Rules Phase 3 (2007)
  • Regulation of anabolic steroids
    • Thresholds for four FDA-permitted or endogenous anabolics
      • Stanozolol
      • Boldenone
      • Nandrolone
      • Testosterone
    • 30-45 days withdrawal time
  • Out-of-competition testing
    • Blood-doping agents – EPO & Darbypoietin
    • Illegal & prohibited drugs
model rules present future withdrawal times research
Model Rules-Present & FutureWithdrawal Times Research
  • Identify drugs with legitimate uses
  • Prioritize drugs into five groups
  • Collect previous science on each drug
  • If science is insufficient then perform administrations on a minimum of 20 horses
  • Plasma is preferred but some drugs will have both urine and plasma collected
  • Ultimate goal…uniform withdrawal time with a corresponding concentration of drug which regulates the withdrawal time
withdrawal times research
Priority Group 1

Acepromazine

Butorphanol

Detomidine

Glycopyrrolate

Lidocaine

Mepivacaine

Methocarbamol

Pyrilamine

Priority Group 2

Boldenone

Dantrolene

Dexamethasone

Firocoxib

Fluphenazine

Hydroxyzine

Nandrolone

Stanozolol

Testosterone

Withdrawal Times Research
withdrawal times research11
Priority Group 3

Albuterol

Betamethasone

Diclofenac

Methylprednisolone

Reserpine

Triamcinolone

Trichlormethiazide

Xylazine

Priority Group 4

Atropine

Beclomethasone

Buscopan

Cromolyn

Isoxsuprine

Pentoxyfylline

Phenytoin

Prednisolone

Withdrawal Times Research
model rules present future withdrawal time database
Model Rules-Present & Future Withdrawal Time Database
  • Withdrawal times posted for 18 jurisdictions and over 70 drugs
  • Database is searchable by drug and by jurisdiction
  • Over 2,000 unique users in first month of availability
  • www.rmtcnet.com, click on “Withdrawal Times” tab at top of page
rmtc present future drug testing initiatives
RMTC-Present & FutureDrug Testing Initiatives
  • Develop strategies to improve drug testing in US:
    • Integrate WADA laboratory standards
    • Overhaul of Laboratory Quality Assurance Programs
    • Development of a post-doctoral recruitment program
    • Development of a business plan for U.S. drug testing infrastructure which includes research and development laboratory
big picture the future
Big picture…the future
  • Beginning to see organizations with “sticks” use them to drive change:
    • Thoroughbred Owners and Breeders Association Graded Stakes Committee
    • Breeder’s Cup
    • NTRA Safety Alliance
    • The Jockey Club Safety Committee
    • Hambletonian Society